Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of BGE-175 in Hospitalized Adults With COVID-19
Conditions
Interventions
BGE-175
Placebo
Locations
26
United States
Banner Health
Mesa, Arizona, United States
Velocity Clinical Research, Chula Vista
Chula Vista, California, United States
Long Beach Medical Center
Long Beach, California, United States
UCI Center for Clinical Research
Orange, California, United States
Sharp Memorial Hospital
San Diego, California, United States
North Colorado Medical Center
Greeley, Colorado, United States
Start Date
March 18, 2021
Primary Completion Date
April 20, 2022
Completion Date
May 19, 2022
Last Updated
July 3, 2023
NCT07189936
NCT04525716
NCT03188796
NCT04527315
NCT05013632
NCT06355232
Lead Sponsor
BioAge Labs, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions